Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
3
30%
Ph phase_4
1
10%
Ph not_applicable
5
50%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
3(33.3%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)

Detailed Status

Completed8
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (33.3%)
Phase 41 (11.1%)
N/A5 (55.6%)

Trials by Status

completed880%
terminated110%
not_yet_recruiting110%

Recent Activity

0 active trials
Showing 5 of 10
not_yet_recruitingnot_applicable

Effect of Chromium Weight Reduction on Adult Asthma Control

NCT07703358
completednot_applicable

Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance

NCT07371169
completedphase_4

Chromium and Insulin Action

NCT00283777
completedphase_1

Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults

NCT00109746
completednot_applicable

Effects of Chromium Picolinate on Food Intake

NCT00477854
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07703358Not Applicable

Effect of Chromium Weight Reduction on Adult Asthma Control

Not Yet Recruiting
NCT07371169Not Applicable

Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance

Completed
NCT00283777Phase 4

Chromium and Insulin Action

Completed
NCT00109746Phase 1

Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults

Completed
NCT00477854Not Applicable

Effects of Chromium Picolinate on Food Intake

Completed
NCT02006914

Novel Therapy for Glucose Intolerance in HIV Disease

Completed
NCT00904306Phase 1

Binge Eating and Chromium Study

Completed
NCT00997659Not Applicable

Chromium's Effect on Insulin Resistance in Obesity

Completed
NCT00332085Phase 1

Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes

Terminated
NCT00128154Not Applicable

Chromium Picolinate for the Treatment of Metabolic Syndrome

Completed

All 10 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
10